Neumora Therapeutics (NMRA) Leases (2022 - 2026)
Neumora Therapeutics' quarterly Leases came in at $358000.0 in Q1 2026, down 60.22% year-on-year from $900000.0 in Q1 2025, and down 14.15% quarter-over-quarter from $417000.0 in Q4 2025.
Neumora Therapeutics has reported Leases for 5 years, with the latest figure at $358000.0 in Q1 2026.
- For the quarter ending Q1 2026, Leases fell 60.22% year-over-year to $358000.0; the trailing twelve-month figure through Mar 2026 stood at $358000.0 (down 60.22% YoY), and the FY2025 full-year result was $417000.0, down 76.53% from the prior year.
- Leases for Q1 2026 stood at $358000.0, down from $417000.0 in the prior quarter.
- The five-year high for Leases was $8.2 million in Q4 2022, with the low at $358000.0 in Q1 2026.
- Average Leases over 5 years is $2.8 million, with a median of $2.2 million recorded in 2024.
- Year-over-year, Leases slumped 38.43% in 2023 and slumped 84.68% in 2025.
- Tracing NMRA's Leases over 5 years: stood at $8.2 million in 2022, then tumbled by 38.43% to $5.1 million in 2023, then tumbled by 64.94% to $1.8 million in 2024, then plunged by 76.53% to $417000.0 in 2025, then decreased by 14.15% to $358000.0 in 2026.
- The last three Leases figures came in at $358000.0 (Q1 2026), $417000.0 (Q4 2025), and $474000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Neumora Therapeutics | 328.27 Mn | 328.27 Mn | - | 358,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 358,000.00 |
| Dec 31, 2025 | 417,000.00 |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | 531,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 4.28 Mn |
| Dec 31, 2023 | 5.07 Mn |
| Sep 30, 2023 | 5.95 Mn |
| Dec 31, 2022 | 8.23 Mn |